Purpose The objective of this study was to evaluate the performance of the built-in MR-based attenuation correction (MRAC) included in the combined whole-body Ingenuity TF PET/MR scanner and compare it to the performance of CTbased attenuation correction (CTAC) as the gold standard. Methods Included in the study were 26 patients who underwent clinical whole-body FDG PET/CT imaging and subsequently PET/MR imaging (mean delay 100 min). Patients were separated into two groups: the alpha group (14 patients) without MR coils during PET/MR imaging and the beta group (12 patients) with MR coils present (neurovascular, spine, cardiac and torso coils). All images were coregistered to the same space (PET/MR). The two PET images from PET/MR reconstructed using MRAC and CTAC were compared by voxel-based and region-based methods (with ten regions of interest, ROIs). Lesions were also compared by an experienced clinician. Results Body mass index and lung density showed significant differences between the alpha and beta groups. Right and left lung densities were also significantly different within each group. The percentage differences in uptake values using MRAC in relation to those using CTAC were greater in the beta group than in the alpha group (alpha group −0.2 ± 33.6 %, R 2 =0.98, p<0.001; beta group 10.31 ± 69.86 %, R 2 =0.97, p<0.001). Conclusion In comparison to CTAC, MRAC led to underestimation of the PET values by less than 10 % on average, although some ROIs and lesions did differ by more (including the spine, lung and heart). The beta group (imaged with coils present) showed increased overall PET quantification as well as increased variability compared to the alpha group (imaged without coils). PET data reconstructed with MRAC and CTAC showed some differences, mostly in relation to air pockets, metallic implants and attenuation differences in large bone areas (such as the pelvis and spine) due to the segmentation limitation of the MRAC method.
Introduction
CT-based attenuation correction (CTAC) is presently accepted as the "gold standard" for attenuation correction of PET data from PET/CT scanners. CT images are created directly in relation to the electron density of the tissues and organs and hence the imaging of a particular tissue is proportional to the attenuation coefficient at PET energy levels (511 keV). On the contrary, MR images are created in relation to the unpaired proton density of the tissues and organs and their relaxation times [1] . MR-based attenuation correction (MRAC) methods consist of creating approximate attenuation coefficient maps from the MR images. Additionally, the use of MR instead of CT imposes a series of specific challenges in terms of attenuation correction to achieve full quantitative PET imaging. The most important challenges are to obtain accurate lung and bone segmentation, the occurrence of MR artefacts (implants, special devices, etc.), the lack of MR signal for the patient table and the additional MR coils, and finally field inhomogeneities and the limited field of view (FOV) leading to image truncation.
Several approaches have been described in the literature to obtain attenuation maps that closely approximate [2] . MRAC approaches can be divided into three main strategies: segmentation-based, atlas-based and PET-based methods. The first group focuses on segmenting the MR images into tissue/organ classes and assigning their respective estimated linear attenuation coefficients (LACs) [3] [4] [5] [6] . In general, the better the segmentation, the closer the attenuation map approximates the gold standard (CTAC) attenuation map. The second group, the atlas-based methods, are based on obtaining a coregistered pair of atlases: MR and corresponding attenuation map (either CT-based or transmission-based). When a new MR image is obtained, it is then coregistered to the MR atlas [7] [8] [9] [10] . The third and last group of methods includes those in which the attenuation correction maps are generated from the PET emission data directly. These techniques follow in general an iterative approach where emission and attenuation maps are updated repeatedly under certain constraints [11] [12] [13] . Although these techniques have shown promising results in time of flight (TOF) systems, their usefulness and stability are still to be proven, and further investigations are needed to evaluate their application in non-TOF scanners. Whole-body techniques are scarce because of the particularities and challenges imposed in both atlas-based and segmentation-based methods: misregistration problems and tissue segmentation/classification failures due to the difficulties in lung segmentation and the proximity of bone and air [4, 9] , as well as intersubject and intrasubject variability in lung density [14] . Finally a new methodology based on simultaneous emission and transmission image acquisition has been recently developed [15] . A method requiring a low-dose transmission source ring and PET detectors with TOF capabilities is showing promising results.
The objective of this study was to evaluate the performance, in terms of PET quantification, of the MRAC method implemented on a sequential whole-body PET/MR scanner for whole-body imaging. PET images from PET/MR reconstructed using MRAC and CTAC were compared in two patient setups, one with MR coils present and one without MR coils within the PET FOV.
Materials and methods

Patients
Included in this study were 26 patients referred for a clinical 18 F-FDG PET/CT scan. The patients were scanned first using a PET/CT scanner and then using a combined PET/MR scanner. The patients received an injection of FDG at a standard clinical dose as specified at our institution (578.3 ± 55.8 MBq, mean ± SD). Patients were divided into two groups: the alpha group (14 patients, 7 men and 7 women, mean age 61 ± 11 years) comprising those without MR coils during PET/MR image acquisition, and the beta group (12 patients, 7 men and 5 women, mean age 64 ± 10 years) comprising those with MR coils present during PET/MR image acquisition. Table 1 shows the patient details and imaging times after FDG injection. The study was approved by the Institutional Review Board of the Mount Sinai School of Medicine. All patients gave written informed consent.
The same supports for the head and legs were used in both scanners so that the patient could be placed in the same position for the two scans to facilitate coregistration of the CT and PET/MR images. These supports were outside the analysed PET FOV (from pelvis to shoulders) and therefore did not affect photon attenuation.
CT imaging
CT images were obtained from the combined PET/CT images (16-slice Discovery LS multidetector CT scanner; GE, Waukesha, WI). A noncontrast low-dose CT scan was acquired. The final matrix size of the CT images was 512× 512 voxels in-plane with a voxel size of 1.37×1.37×3.75 mm.
PET/MR scanner
Immediately after the PET/CT scan, patients were taken to the PET/MR facility. PET/MR images were acquired using a combined whole-body PET/MR system (Ingenuity TF; Philips Healthcare, Cleveland, OH) [16] . PET images were acquired in 3-D mode using TOF information (a standard mode for this system). PET/MR images were acquired using whole-body and partial-body protocols: 2 to 3 min per bed position (159.4 ± 59.7 s), 7 to 11 bed positions, with 45 slices per bed position and a 55 % overlap between bed positions (a standard mode for this system). Images were reconstructed with a matrix size of 144×144 with a voxel size of 4×4× 4 mm, using a TOF, list-mode, blob-based OSEM algorithm with three iterations and 33 subsets using corrections for normalization, dead time, attenuation, scatter, random coincidences, sensitivity and decay.
PET/MR attenuation correction
MRAC
Since the objective of this study was to compare the manufacturer's built-in MRAC method with the gold standard CTAC, all PET images were reconstructed using the built-in method for attenuation correction implemented on the Ingenuity TF PET/MR scanner (v3.7). Full details of this method have been reported previously [1] . Briefly, a specific MR sequence (called atMR, for MRAC) was run prior to PET acquisition. The atMR sequence, acquires only with the integrated body coil of the MR scanner, matches the PET dimensions and allows both anatomical detail and attenuation correction, similar to the procedure in low-dose CT imaging with a standard PET/CT camera. The atMR image was segmented into three tissue classes (air, soft tissue and lungs) and , respectively). An attenuation template of the patient table and of those MR coils for which the manufacturer provided an attenuation template were incorporated into the attenuation map to correct for their attenuation. As the objective of this study was to evaluate the global effect of the presence of clinical MR coils in the PET FOV, four different coils were used in the beta group: a cardiac coil (32 channel), a SENSE XL torso coil (16 elements), a neurovascular SENSE coil (16 elements) and a SENSE spine coil (15 elements). The built-in MRAC method developed by the manufacturer provided templates for both fixed-position coils, the neurovascular and spine coils, but by default the standard procedure of the PET/MR scanner does not provide an attenuation template for the flexible coils (cardiac and torso). While the posterior parts of these flexible coils remain on the patient table, the standard procedure requires that their anterior parts be detached from the patient before starting the PET acquisition. Examples of the attenuation templates for the coils used in this study have been reported previously [17] . No truncation compensation method was used for the MRAC method.
CTAC
In order to provide PET/MR with CTAC, the CT images were rigidly coregistered to the PET/MR space, similar to a previously reported procedure [18] , first using SPM8 software (Statistical Parametric Mapping 8; Wellcome Trust Centre for Neuroimaging, UCL, London, UK). To avoid possible misregistration on areas of the arms and legs that could bias the results, coregistration and therefore PET analysis was only performed from the shoulders to the pelvic area. Fine manual adjustments based on anatomical features were applied when needed. The coregistered CT images were then masked to exclude the CT table and then smoothed with a Gaussian kernel (4 mm) to match the PET resolution before reslicing them into the PET/MR image space (voxel size 4×4×4 mm). The resliced images were then converted into attenuation coefficients applying the bilinear method implemented in the GE Discovery LS PET/CT scanner [19] . The CTAC maps were finally included in the normal reconstruction procedure of the PET/MR scanner in which the scanner automatically adds the PET/MR patient table and the coil templates (when present) to the final attenuation correction map.
PET quantification PET images from PET/MR images were reconstructed using MRAC and CTAC for comparison. These reconstructed PET images are called here MRAC and CTAC images, respectively. The images were compared per patient applying a voxelbased and a region-based method. Differences (mean ± SD) are expressed as percentages, taking CTAC as the gold standard (denominator of the equation).
Voxel-based comparison
An in-house program was developed in Matlab (Mathworks, Natick, MA) to provide voxel-based comparison of the PET images. A patient-specific mask automatically generated on the PET/MR images was used to avoid noise-only voxels that could bias the comparison. Only the images of the coregistered area between the shoulders and the pelvis were compared. Bland-Altman [20] and correlation plots were generated for all patients in each group using standardized uptake values (SUV) to quantify the PET images [21] .
Region-based comparison
Ten regions of interest (ROIs) were drawn following the anatomy on the coregistered CT images: the aortic arch, thoracic aorta, heart, liver, left and right kidneys, left and right lungs, spine and soft tissue. Soft tissue ROIs were placed in muscle and soft tissue areas at the back of the shoulders (above the lungs) and the pelvic area. Spine ROIs were placed just above the pelvis. A total of ten slices per ROI were drawn on consecutive axial images. These ROIs were then applied to the coregistered PET images from PET/MR (both MRAC and CTAC). The mean and maximum SUVs (SUVmean and SUVmax, respectively) were determined from the PET images. The average of SUVmean and SUVmax for all slices was calculated for each ROI in all patients. Bland-Altman [20] and correlation plots were generated for all patients in each group for both SUVmean and SUVmax. CT images of the lungs (which are known to show variability in density [14] ) were also quantified to compare their variability and the potential impact of assigning them a unique LAC (0.022 cm −1 ).
Evaluation of lesions
An experienced clinician (J.M., Director of Nuclear Medicine Division, with more than 20 years of experience) reported the same lesions of the PET images (MRAC and CTAC) applying the same standard clinical procedures applied to the PET images at Mount Sinai Hospital using SUVmax. The clinician reported a total of 168 lesions, defined as areas with abnormal (increased) FDG uptake. Lesions were then classified into three types following the criteria of the clinician according to the degree of malignancy: normal (healthy) tissue with increased uptake (described as normal/increased uptake), inflammatory/degenerative lesions and tumour lesions. Bland-Altman [20] and correlation plots were also generated for all patients in each group. Additional comments reported by the clinician concerning differences between the images were also included.
Statistical analysis
The results are presented as mean ± SD percentage differences in SUVs between images reconstructed using MRAC and those reconstructed using the gold standard, CTAC.
Pearson's correlation analysis and appropriate Student's t-tests were performed using the Statistical Package for the Social Sciences (SPSS) software, ver. 21.0 (SPSS, IBM Inc, Chicago, IL). Statistical significance was assumed for p values <0.05.
Results Table 1 shows the patient details for both the alpha and beta groups. There were no statistically significant differences in patient age, sex, weight, height or injected dose between the groups. However, there were significant differences in body mass index (BMI) between the groups (p=0.02). Figure 1 shows all images in a representative patient (atMR, CT, and PET with MRAC and CTAC reconstruction) coregistered into the same space (PET/MR image space). There was no statistically significant differences between the injection times and the start times of the PET/MR scan between alpha and beta groups.
Voxel-based comparison Figure 2 shows Bland-Altman plots for the voxel-based comparison of MRAC and CTAC PET reconstruction for both the alpha and beta groups. Correlation plots are shown in Supplementary Fig. 1 . Table 2 shows a summary of all voxel-based results. All differences were statistically significant. Figure 3 shows images in representative patients in the alpha and beta groups showing the bias in PET data between MRAC and CTAC reconstruction (in percent difference from CTAC). The variability was greater in the beta group patient, confirming the differences in the values for the two groups shown in Table 2 and Fig. 2 .
Region-based comparison Figure 4 shows Bland-Altman plots for the region-based comparisons of MRAC and CTAC PET reconstruction for both the alpha and beta groups for all ten ROIs. SUVmean values for MRAC over all ROIs were lower than those for CTAC for both the alpha and beta groups (alpha −8.05 ± 7.37 %, p<0.001; beta −3.02 ± 11.76 %, p=0.03; Table 3 ). SUVmax followed a similar pattern (Table 3) . Similar to the voxel-based analysis, the beta group showed greater variability than the alpha group.
For individual ROIs, all ROI SUVs in both the alpha and beta groups were underestimated using MRAC relative to CTAC by less than 10 %, except for the spine (−12.03 %), right lung (−10.51 %) and heart (−10.45 %) for SUVmean, and the right lung (−22.68 %) and spine (−10.83 %) for SUVmax, all in the alpha group (Supplementary Table 1 ). All of these differences in the alpha group were significant (p<0.01). In the beta group, the difference in SUVmax was more than 10 % only for the right lung (−14.73 %), but this just failed to achieve statistical significance (p=0.06). Both SUVmean and SUVmax were overestimated using MRAC only for the left and right kidneys in the beta group (SUVmean 3.28 % for the left kidney, 1.95 % for the right kidney; SUVmax 4.65 % for the left kidney, 2.36 % for the right kidney). However, these differences were not statistically significant. There were significant differences in lung density (Hounsfield units) on the coregistered CT images between the alpha and beta groups, with large variability within each group (Table 4) . Moreover, in the same group, the right and left lungs also showed significant differences ( Table 4) .
MR
Evaluation of lesions Figure 5 shows Bland-Altman plots for the comparisons of MRAC and CTAC PET reconstruction as reported by the clinician for a total of 168 lesions (74 lesions in the alpha group, 94 lesions in the beta group). In the alpha group SUVmax values obtained using MRAC were lower than those obtained using CTAC (−6.01 ± 9.31 %, p<0.001), but in the beta group SUVmax values obtained using MRAC were higher than those obtained using CTAC, but not significantly (1.76 ± 18.46 %, p=0.64; Table 3 ). Uptake in the three lesion types was underestimated using MRAC relative to CTAC, except in the normal/increased uptake group (11.85 ± 45.74 %) and in tumour lesions (1.65 ± 11.7 %), both in the beta group (Supplementary Table 2) .
Comparing all images, PET CTAC and MRAC images showed some differences. Most of these were differences due to air pockets in the colon area (12 patients), differences around large bone areas such as the pelvis and spine (17 patients), differences in the liver (4 patients) and differences due to metallic implants (2 patients). Three patients had no visible differences between images reconstructed using CTAC and MRAC. The atMR images showed flow artefacts that created a visible phantom replica of the aortic arch in the lungs (23 patients), respiratory motion artefacts in the chest (15 patients), metallic implant artefacts (8 patients) and body truncation (7 patients) (Fig. 6) . Finally, the MRAC attenuation map showed metallic artefacts (9 patients), errors in lung segmentation (5 patients), air in soft tissue areas (5 patients), body truncation (6 patients) and other artefacts due to noise in the atMR image (6 patients). Five patients had no MRAC attenuation map errors. In general, not all the artefacts and errors in the atMR images were translated into the attenuation maps or the final PET MRAC image (Supplementary Table 3 ).
Discussion
This study was a comparison of whole-body PET images in two groups of patients, one imaged with coils present and one without coils within the PET FOV, with different attenuation correction methods for the combined whole-body PET/MR system. Although previous studies have compared MRAC and CTAC or transmission-based attenuation correction [1, 18] , to our knowledge this is the first study comparing the same PET/MR scan results using MRAC and CTAC methods including groups imaged with coils present and without coils and evaluating lesions in all the images.
In both the voxel-based and ROI-based comparisons, MRAC reconstruction generally overestimated PET uptake values in the beta group with greater variability (−0.2 ± 33.6 % in the alpha group and 10.31 ± 69.86 % in the beta group for the voxel-based comparison; −8.05 ± 7.37 % in the alpha group and −3.02 ± 11.76 % in the beta group for the ROI-based comparison; Figs. 2, 3 and 4 and Table 3 ). It has been reported that BMI can have an important impact on PET quantification [22] . This could explain some of the differences between the two groups since BMI was significantly higher in the beta group (Table 1) . Differences in lung density between the alpha and beta groups could also explain some of the , corresponding −770 HU) was assigned to the whole lung, while in reality lungs showed a large range of density values that are directly translated to LACs (Table 4) . Furthermore, there were significant differences even within the same group between the right and left lungs, which could also explain some of the difference in the ROI results (Supplementary Table 1 ). The increased attenuation and scatter fractions due to the presence of the coils could also explain the higher variability between the two groups. Additionally, the small physical tolerances in placing the coil in the patient table possibly resulting in slight misplacement in relation to the calculated template placement and the fact that the posterior parts of the cardiac and torso coils were not corrected for may also have affected PET quantification and may have had an impact on both bias and variability [23, 24] . However, since the scope of this study was not to evaluate particular effects of specific coils but rather to compare two groups of patients imaged with MR coils present and without MR coils, further studies are required to evaluate the effects of particular coils on the final reconstructed PET images. It is also worth noting that our mean relative percentage differences were averages of positive and negative values, and (as shown in Fig. 3 ) local differences may have been higher than the average values presented here. In terms of the lesions reported, the beta group again showed higher PET values with MRAC than with CTAC compared with the alpha group (−6.01 ± 9.31 % in the alpha group; 1.76 ± 18.46 % in the beta group), similar to the results of the voxel-based and ROI-based comparisons (Fig. 5) . In general, uptake values in lesions of all three types following malignancy (lesions with normal/increased uptake, inflammatory/degenerative lesions, and tumour lesions) were underestimated in the alpha group and overestimated in the beta group except for inflammatory/degenerative lesions that were also slightly underestimated (−3.13 ± 16.35 %). These results also agree with the overall overestimation of uptake in the beta group. Image artefacts including flow ghosting, metallic implants and body truncation (Fig. 6 ) may potentially bias the clinical interpretation of PET/MR images in a similar fashion to CT artefacts (produced by metallic implants, for example). Therefore, these effects need to be known and addressed properly.
The quantitative results of this study are in accordance with those of previous studies. In particular, the studies by Schulz et al. [1] and by Schramm et al. [18] similarly compared MRAC and CTAC with the same attenuation correction method as implemented in this study. However, our study differed from these previous studies in several aspects. First, Schulz et al. used a standard clinical PET/CT scanner while we used a PET/MR scanner to acquire the PET data, since the objective of this study was to evaluate the feasibility of this new PET/ MRI technology. Second, we introduced a second group of subjects imaged with MR coils present while neither of the two studies included such a group. This is of great interest, since most future PET/MR studies will indeed include coils to improve the quality of the clinical MR images. Finally, our study provided additional lesion evaluation in PET images reconstructed using MRAC and CTAC, which was not performed in the previous studies. Martinez-Moller et al. [4] and Eiber et al. [25] found underestimation of bone lesions by less than 8 % when using CT-segmented images using four classes (background, lungs, fat and soft tissue) compared with CTAC. Keereman et al. found underestimation by between 10 % and 15 % for spine and femur lesions when spongious bone was considered as soft tissue and between 10 % and 20 % when cortical bone was considered as soft tissue [26] . Similarly, Hofmann et al. found underestimation by more than 10 % in almost 85 % of the ROIs placed in bone areas when using an MR segmentation method with five tissue classes (not including bone) [27] .
However, this study had some limitations. First, the study did not compare MRAC methods that include bone segmentation to evaluate whether bone segmentation could improve PET quantification nor did it evaluate the impact of potential misclassification errors. Second, the study was limited to the analysis of whole-body protocols. Brain imaging, known to be more prone to MRAC underestimation when bone segmentation is not included [28] , was not included in the study. Third, the study did not address the effect of potential misregistration that could have led to differences in PET quantification.
Although nonrigid coregistration appears in principle as a natural option that achieves very good quality results in brain imaging [10, 29] , whole-body nonrigid coregistration is still not optimal [8] and, as explained by Beyer et al. [9] , could lead to increased quantification bias due to incorrect repositioning of certain challenging areas. For this reason we applied rigid registration, in a similar manner to Schramm et al. [18] , limiting the effect of nonrigid misregistration by ensuring the use of the same supports to position the patient similarly in both scanners (Fig. 1 ). In addition, the distribution of bias shown in Fig. 3 does not suggest global misregistration errors. Our group has also successfully used a similar strategy in the analysis of preclinical images, showing coregistration errors smaller than the resolution of the PET scanner (5 mm) [30] . Despite these efforts some of the differences between MRAC and CTAC images could still potentially have been due to this effect. Another limitation is that the results of this study cannot be extrapolated to other PET/MR systems as the technology and attenuation correction methods implemented differ considerably. Finally, this study did not address the use of the MR images for further clinical evaluation (other than their use for attenuation correction and anatomical fusion similar to use of low-dose CT in clinical standard PET/CT). The use of MRI in clinical evaluation could be of great advantage compared to CT in many patients due to its superior soft-tissue contrast, although this point is yet to be proved. However, we limited our study to the impact of attenuation correction methods on the final PET quantification. This study evaluated the global effects of the use of different clinical MR coils on the final PET quantification, rather than focusing on the effects of a particular MR coil. As we have previously discussed, more detailed studies should focus on the precise effects of specific MR coils on PET quantification, in a similar manner to previous studies [23, 24, [31] [32] [33] . Despite these limitations, the study showed that the MRAC method implemented in the Ingenuity TF PET/MR scanner resulted in quantification of PET images that differed overall by less than 10 % compared to CTAC. However, some ROIs and lesions showed higher differences, in particular the spine, lung and heart ROIs. Further studies are required to address these limitations.
Conclusion
This study showed that the built-in MRAC strategy in the PET/MR scanner, correcting for the presence of MR coils other than flexible coils, tended to increase variability of PET quantification in a comparison of a group of patients imaged in the presence of MR coils to a group imaged without coils. Lesions were underestimated overall by −6 % when compared to PET CTAC in the alpha group (no MR coils) and overestimated by 2 % in the beta group (MR coils included). Potential MR artefacts need to be properly addressed to minimize their impact in clinical evaluation. In summary, the MRAC method implemented in this combined PET/MR scanner underestimated uptake in PET images overall by less than 10 % in comparison with CTAC. However, some ROIs and lesions showed higher differences (large bone areas such as the spine) for both SUVmean and SUVmax.
